🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety, tolerability, pharmacokinetics, pharmaco...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01624636
This study will assess the safety and efficacy of LFG316 in patients with a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01535950
This was a multi-center, randomized, active-controlled, open-label study. A...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-20
Trial ID
NCT01526889
Treatments Being Tested
This study was conducted in two parts; Part A and Part B: Part B was initia...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01-25
Trial ID
NCT01527500
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of 12 (eve...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-25
Trial ID
NCT02515942
Treatments Being Tested
The purpose of this study was to determine whether LFG316 can induce a hema...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-09-09
Trial ID
NCT02534909
This was a randomized, SoC-controlled, open-label, multi-center study in pa...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2016-04-22
Trial ID
NCT02763644
Treatments Being Tested
This study will assess the safety, tolerability, and serum pharmacokinetics...
Status
Completed
Location
Retinal Consultants of Arizona,
Start Date
2010-11
Trial ID
NCT01255462
Investigate whether concomitant treatment with intravenous immunoglobulin (...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-08-26
Trial ID
NCT02878616